STI ends September at 5,675.88, down 1.4%
Katrina Group was the month's strongest performer.
The Straits Times Index (STI) ended September at 5,675.88, down 1.4% for the month, after hitting a record 5,828.5 on 4 September.
The two STI exchange-traded funds, the SPDR STI ETF and the Amova STI ETF, drew net inflows of $293m in September.
Meanwhile, the FTSE ST Catalist Index rose 2.4%, led by iX Biopharma, up 25.9% after a US Government declaration opened an emergency-use pathway for its Wafermine drug.
The stock now makes up 19% of the index, up from about 5% in March. The FTSE ST All-Share Technology Index gained 1.7%, whilst the FTSE ST REIT Index fell 5.7%.
Katrina Group was the month's strongest performer amongst about 180 actively traded stocks, surging 270% after a BYD-linked dealer acquired a 5% stake for about $300,000.
Accrelist followed with a 39.3% gain.
Institutional investors were net sellers of about $1.02b, whilst retail investors bought about $1.13b.
Institutions favoured utilities, with about $106m of net inflows led by Sembcorp Industries, and technology, with about $81m led by AEM.
They sold financial services, REITs, real estate excluding REITs and telecommunications, which retail investors bought.
Meanwhile, non-oil domestic exports rose 46.2% year on year in August, and industrial production grew 15.4%.
The median private-sector forecast for 2026 gross domestic product growth in the Monetary Authority of Singapore's September survey rose to 5.0% from 3.5% in June, with 3.1% projected for 2027.